{"DataElement":{"publicId":"2542504","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Malignant Neoplasm Primary Site","preferredDefinition":"the primary site of a malignant neoplasm in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_MALNEO_PRM_SITE","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2542502","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Malignant Neoplasm Primary Location","preferredDefinition":"information related to the original anatomical position within the body for a tumor composed of atypical neoplastic in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_MALNEO_PRM_LCTN","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"3081927","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Malignant Neoplasm","preferredDefinition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes; opportunistic infections (usually pneumocystis carinii pneumonia, cytomegalovirus (CMV) infections, tuberculosis, candida infections, and cryptococcosis); and the development of malignant neoplasms (usually non-Hodgkin's lymphoma and Kaposi's sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood. Generalized lymphadenopathy, fever, weight loss, and chronic diarrhea are common symptoms of AIDS. The patients usually die either of opportunistic infections or malignant neoplasms. -- 2004:A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues.  Malignant neoplasms usually metastasize to distant anatomic sites and may recur after excision.  The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin's and non-Hodgkin's lymphomas, leukemias, melanomas, and sarcomas. -- 2004","longName":"C2851:C9305","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acquired Immunodeficiency Syndrome","conceptCode":"C2851","definition":"A syndrome resulting from the acquired deficiency of cellular immunity caused by the human immunodeficiency virus (HIV). It is characterized by the reduction of the Helper T-lymphocytes in the peripheral blood and the lymph nodes. Symptoms include generalized lymphadenopathy, fever, weight loss, and chronic diarrhea. Patients with AIDS are especially susceptible to opportunistic infections, tuberculosis, candida infections, and cryptococcosis), and the development of malignant neoplasms (usually non-Hodgkin lymphoma and Kaposi sarcoma). The human immunodeficiency virus is transmitted through sexual contact, sharing of contaminated needles, or transfusion of contaminated blood.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"85C9A655-BA83-A9AE-E040-BB89AD430F8A","latestVersionIndicator":"Yes","beginDate":"2010-05-04","endDate":null,"createdBy":"SHIDED","dateCreated":"2010-05-04","modifiedBy":"ONEDATA","dateModified":"2010-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207144","version":"1","preferredName":"Primary Location","preferredDefinition":"Occurring first in time or sequence; original. (American Heritage Dictionary):A position, site, or point in space where something can be found.","longName":"C25251:C25341","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary","conceptCode":"C25251","definition":"Occurring first in time or sequence; original; of greatest rank or importance or value.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Location","conceptCode":"C25341","definition":"A position, site, or point in space where something can be found.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-19C7-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"225ED30E-764E-6E95-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-02-13","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2542503","version":"1","preferredName":"Acquired Immunodeficiency Syndrome Malignant Neoplasm Primary Site","preferredDefinition":"the primary site of a malignant neoplasm in an AIDS (acquired immunodeficiency syndrome, resulting from the acquired deficiency of cellular immunity caused by the HIV/human immunodeficiency virus) trial.","longName":"AIDS_MALNEO_PRM_SITE","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"KS","valueDescription":"Kaposi sarcoma","ValueMeaning":{"publicId":"2568842","version":"1","preferredName":"Kaposi sarcoma","longName":"2568842","preferredDefinition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kaposi Sarcoma","conceptCode":"C9087","definition":"A malignant neoplasm characterized by a vascular proliferation which usually contains blunt endothelial cells. Erythrocyte extravasation and hemosiderin deposition are frequently present. The most frequent site of involvement is the skin; however it may also occur internally. It generally develops in people with compromised immune systems including those with acquired immune deficiency syndrome (AIDS).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D9F7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-03-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-29","modifiedBy":"UMLLOADER_COPPAPRD","dateModified":"2009-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EDDEF-797D-6EC1-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"NHL","valueDescription":"Non-Hodgkin lymphoma","ValueMeaning":{"publicId":"2568326","version":"1","preferredName":"Non-Hodgkin lymphoma","longName":"2568326","preferredDefinition":"Distinct from Hodgkin lymphoma both morphologically and biologically, Non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Non-Hodgkin Lymphoma","conceptCode":"C3211","definition":"Distinct from Hodgkin lymphoma both morphologically and biologically, non-Hodgkin lymphoma (NHL) is characterized by the absence of Reed-Sternberg cells, can occur at any age, and usually presents as a localized or generalized lymphadenopathy associated with fever and weight loss. The clinical course varies according to the morphologic type. NHL is clinically classified as indolent, aggressive, or having a variable clinical course. NHL can be of B-or T-/NK-cell lineage.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D7F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-02-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-02-02","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EDDEF-798F-6EC1-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"HD","valueDescription":"HD","ValueMeaning":{"publicId":"2581963","version":"1","preferredName":"HD","longName":"2581963","preferredDefinition":"HD","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D38-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"SHIDED","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EDDEF-79A1-6EC1-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"Anal","valueDescription":"Anal Canal","ValueMeaning":{"publicId":"2571096","version":"1","preferredName":"Anal Canal","longName":"2571096","preferredDefinition":"The lower opening of the digestive tract, lying in the cleft between the buttocks, through which fecal matter is extruded.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Anal Canal","conceptCode":"C12375","definition":"The terminal section of the alimentary canal, which extends from the anorectal junction and ends at the anal opening.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-E2C5-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-07-20","endDate":null,"createdBy":"MAESKEB","dateCreated":"2004-07-20","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EDDEF-79B3-6EC1-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"Cervical","valueDescription":"Cervical","ValueMeaning":{"publicId":"2565996","version":"1","preferredName":"Cervical","longName":"2565996v1.00","preferredDefinition":"Relating to a neck, or cervix, in any sense.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cervical","conceptCode":"C12844","definition":"Relating to a neck, or cervix, in any sense.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-CED9-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-05-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-05-27","modifiedBy":"KUMMEROA","dateModified":"2023-09-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EDDEF-79BE-6EC1-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"Other primary site","valueDescription":"Other primary site","ValueMeaning":{"publicId":"2581964","version":"1","preferredName":"Other primary site","longName":"2581964","preferredDefinition":"Other primary site","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0D39-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"SHIDED","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"225EF233-11ED-660A-E044-0003BA3F9857","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","deletedIndicator":"No"},{"value":"Hodgkin Lymphoma (HL)","valueDescription":"AIDS-Related Hodgkin Lymphoma","ValueMeaning":{"publicId":"4722459","version":"1","preferredName":"AIDS-Related Hodgkin Lymphoma","longName":"4722459","preferredDefinition":"Hodgkin lymphoma secondary to AIDS. An increased incidence of Hodgkin lymphomas has been observed in HIV positive patients. Most cases are morphologically classified as lymphocyte depleted or mixed cellularity Hodgkin lymphomas.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Hodgkin Lymphoma","conceptCode":"C9279","definition":"Hodgkin lymphoma secondary to AIDS. An increased incidence of Hodgkin lymphomas has been observed in HIV positive patients. Most cases are morphologically classified as lymphocyte depleted or mixed cellularity Hodgkin lymphomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F86183D-E17A-2456-E050-BB89AD4355BA","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9760881-6DA3-7026-E053-4EBD850A3498","beginDate":"2020-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"Non-Hodgkin Lymphoma (NHL)","valueDescription":"AIDS-Related Non-Hodgkin Lymphoma","ValueMeaning":{"publicId":"4722457","version":"1","preferredName":"AIDS-Related Non-Hodgkin Lymphoma","longName":"4722457","preferredDefinition":"A non-Hodgkin lymphoma that develops in a patient with AIDS.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Non-Hodgkin Lymphoma","conceptCode":"C5051","definition":"A non-Hodgkin lymphoma that develops in a patient with AIDS.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F86183D-E154-2456-E050-BB89AD4355BA","latestVersionIndicator":"Yes","beginDate":"2015-02-20","endDate":null,"createdBy":"LUY","dateCreated":"2015-02-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9760881-6DB8-7026-E053-4EBD850A3498","beginDate":"2020-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"Kaposi Sarcoma (KS)","valueDescription":"AIDS-Related Kaposi Sarcoma","ValueMeaning":{"publicId":"4722339","version":"1","preferredName":"AIDS-Related Kaposi Sarcoma","longName":"4722339","preferredDefinition":"The most aggressive form of Kaposi sarcoma. It presents in patients who are infected with the human immunodeficiency virus. It can affect the skin and internal organs.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"AIDS-Related Kaposi Sarcoma","conceptCode":"C3992","definition":"The most aggressive form of Kaposi sarcoma. It presents in patients who are infected with the human immunodeficiency virus. It can affect the skin and internal organs.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0F78C75D-7C54-2AC1-E050-BB89AD437AC5","latestVersionIndicator":"Yes","beginDate":"2015-02-19","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2015-02-19","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9760881-6DCD-7026-E053-4EBD850A3498","beginDate":"2020-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"Lung","valueDescription":"Lung","ValueMeaning":{"publicId":"5400972","version":"1","preferredName":"Lung","longName":"5400972","preferredDefinition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Lung","conceptCode":"C12468","definition":"One of a pair of viscera occupying the pulmonary cavities of the thorax, the organs of respiration in which aeration of the blood takes place. As a rule, the right lung is slightly larger than the left and is divided into three lobes (an upper, a middle, and a lower or basal), while the left has two lobes (an upper and a lower or basal). Each lung is irregularly conical in shape, presenting a blunt upper extremity (the apex), a concave base following the curve of the diaphragm, an outer convex surface (costal surface), an inner or mediastinal surface (mediastinal surface), a thin and sharp anterior border, and a thick and rounded posterior border.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"39D1406D-408E-7B4F-E050-BB89AD43550A","latestVersionIndicator":"Yes","beginDate":"2016-08-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-08-11","modifiedBy":"KUMMEROA","dateModified":"2022-06-17","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9760881-6DD8-7026-E053-4EBD850A3498","beginDate":"2020-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"},{"value":"Colon","valueDescription":"Colon","ValueMeaning":{"publicId":"2567239","version":"1","preferredName":"Colon","longName":"2567239","preferredDefinition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Colon","conceptCode":"C12382","definition":"The part of the large intestine measured from the cecum to the rectum consisting of ascending, transverse, descending and sigmoid portions. The purpose of the colon is to remove water from digested food prior to excretion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D3B4-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A9760881-6DE2-7026-E053-4EBD850A3498","beginDate":"2020-07-02","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2020-07-02","modifiedBy":"ONEDATA","dateModified":"2020-07-02","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008526","version":"1","preferredName":"Anatomic Sites","preferredDefinition":"locations or structures in the human body.","longName":"ANAT_SITES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B1ED0F8B-4D91-332D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-16","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-16","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2261687","version":"1","preferredName":"Site","preferredDefinition":"Position in relation to the surroundings.","longName":"C37901","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Site","conceptCode":"C37901","definition":"A position in relation to its surroundings.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F9FD4EEB-2626-0B27-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-11","endDate":null,"createdBy":"PWEST","dateCreated":"2005-07-11","modifiedBy":"ONEDATA","dateModified":"2005-07-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"225EDDEF-7960-6EC1-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"CAMPBELB","dateModified":"2020-07-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"7283431","version":"1","longName":"CRF CDEs","context":"AMC","ClassificationSchemeItems":[{"publicId":"7283433","version":"1","longName":"Baseline Evaluations","context":"AMC"}]}],"AlternateNames":[{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"PRMALIG_MHLOC","type":"OID, AMC","context":"AMC"},{"name":"OTHMALIG_MHLOC","type":"OID, AMC","context":"AMC"}],"ReferenceDocuments":[{"name":"Primary site","type":"Preferred Question Text","description":"Primary site","url":null,"context":"CTEP"}],"origin":"AMC CRF:AIDS Malignancy Consortium Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"225EDF12-B0CE-6E9F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"SHIDED","dateCreated":"2006-11-16","modifiedBy":"COLLIED","dateModified":"2020-07-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}